339 related articles for article (PubMed ID: 12789273)
1. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
2. Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis.
Liu S; Mirza A; Wang L
Methods Mol Biol; 2004; 281():33-54. PubMed ID: 15220520
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
5. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.
Kannan K; Kaminski N; Rechavi G; Jakob-Hirsch J; Amariglio N; Givol D
Oncogene; 2001 Jun; 20(26):3449-55. PubMed ID: 11423996
[TBL] [Abstract][Full Text] [Related]
6. Comparative, genome-scale transcriptional analysis of CHRF-288-11 and primary human megakaryocytic cell cultures provides novel insights into lineage-specific differentiation.
Fuhrken PG; Chen C; Miller WM; Papoutsakis ET
Exp Hematol; 2007 Mar; 35(3):476-489. PubMed ID: 17309828
[TBL] [Abstract][Full Text] [Related]
7. DNA microarrays identification of primary and secondary target genes regulated by p53.
Kannan K; Amariglio N; Rechavi G; Jakob-Hirsch J; Kela I; Kaminski N; Getz G; Domany E; Givol D
Oncogene; 2001 Apr; 20(18):2225-34. PubMed ID: 11402317
[TBL] [Abstract][Full Text] [Related]
8. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
9. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
Schavolt KL; Pietenpol JA
Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
[TBL] [Abstract][Full Text] [Related]
10. Methods to study p53-repressed promoters.
Dumont P; Della Pietra A; Murphy ME
Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528
[TBL] [Abstract][Full Text] [Related]
11. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y
Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583
[TBL] [Abstract][Full Text] [Related]
12. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles AI; Bemmels NA; Foraker AB; Harris CC
Cancer Res; 2001 Sep; 61(18):6660-4. PubMed ID: 11559530
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration.
Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH
IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218
[TBL] [Abstract][Full Text] [Related]
14. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
15. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
[TBL] [Abstract][Full Text] [Related]
17. Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis.
Fleischer A; Duhamel M; Lopez-Fernandez LA; Muñoz M; Rebollo MP; Alvarez-Franco F; Rebollo A
Immunol Lett; 2007 Sep; 112(1):9-29. PubMed ID: 17651815
[TBL] [Abstract][Full Text] [Related]
18. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
[TBL] [Abstract][Full Text] [Related]
20. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]